We are dedicated to providing outstanding customer service and being reachable at all times.
tRNAs are some of the most heavily modified molecules in the cell, making them difficult to analyse with standard sequencing methods. CD Genomics' nano tRNA sequencing service uses ONT direct tRNA sequencing to capture full-length, native tRNA molecules, providing accurate tRNAome profiling, modification-aware analysis, and quantitative abundance measurements in a single workflow.
Our service helps research, biotech, and pharma teams address long-standing challenges in tRNA biology, including the inability to detect modification patterns, isoacceptor usage, or native structural features with traditional NGS. By sequencing tRNAs directly—without cDNA synthesis or PCR—we retain native chemical modifications and reveal molecular signatures that drive translational control.

At a glance:
tRNAs play a central role in protein synthesis, yet they remain one of the most challenging RNA classes to analyse. Their short length, strong secondary structures, and dense chemical modifications make them challenging to sequence with traditional RNA-seq or mass-spectrometry approaches. These limitations prevent many teams from understanding how tRNA abundance, isoacceptor usage, and modification patterns shape translation efficiency across cells, tissues, or disease models.
Nano tRNA sequencing is a specialised approach that uses Oxford Nanopore's direct RNA technology to read full-length, native tRNA molecules without cDNA synthesis or PCR. This capability is critical because tRNAs carry more than 150 known chemical modifications, many of which are lost, altered, or masked during reverse transcription in conventional RNA-seq.
In nano tRNA sequencing, individual tRNAs pass through a nanopore, generating electrical signals that reflect both their nucleotide sequence and their modification status. These signals allow researchers to quantify tRNA abundance, distinguish isoacceptors, and identify modification signatures across the tRNAome. Because this method captures each molecule directly, it retains the native biochemical information required for epitranscriptomic studies.
Nano tRNA sequencing is particularly valuable for projects exploring translation dynamics, stress adaptation, metabolic regulation, or drug-response mechanisms where both tRNA expression and modification states influence protein synthesis. For readers interested in nanopore-based RNA chemistry, our Nanopore Direct RNA Sequencing page provides further detail on signal interpretation and model-based modification calling.
Direct nanopore sequencing preserves original chemical modifications, enabling modification-aware interpretation that traditional cDNA-based methods cannot support.
Our platform quantifies individual tRNA species, isoacceptors, and decoding patterns, supporting studies of translation regulation and adaptive responses.
Nanopore current signals reveal modification signatures such as Ψ, m¹A, m⁷G, i⁶A, U34 variants, and other chemical marks relevant to translational control.
Optimised basecalling models ensure reliable mapping of tRNAs, which are often missed or misread in standard RNA-seq pipelines.
Enables investigations into stress pathways, metabolic regulation, drug interactions, and ribosome function in non-clinical studies.
Suitable for any organism, including microbes, plants, model animals, and human-derived samples.
Our team offers basic and advanced tRNAome analysis options that match the needs of research groups, biotech teams, and pharmaceutical programs.
Data are delivered with clarity and structure suitable for internal R&D, regulatory documentation (research-use only), or publication.
tRNAs represent a small fraction of total RNA. We begin by isolating the small RNA population to enhance the proportion of tRNA molecules in the sample. This improves sequencing depth, reduces background noise, and increases the sensitivity of isoacceptor quantification.
Native tRNAs contain aminoacylation at their 3′ ends. These chemical groups interfere with adapter ligation and must be removed. Controlled deacylation exposes the 3′ hydroxyl group, enabling efficient and specific adaptor attachment. Barcoding options support multi-sample or multi-condition studies.
During sequencing, individual tRNA molecules pass through a nanopore channel embedded in a membrane. Each nucleotide—and its chemical modifications—produces distinct electrical current signatures. This enables:
Because nanopore sequencing captures native RNA structure, it is well suited for modification-rich tRNAs that conventional RNA-seq cannot accurately resolve.
The resulting signal and sequence data are processed through tRNA-optimised computational tools. These specialised algorithms improve read mapping, detect modification signatures, and quantify isoacceptor abundance with higher confidence than general RNA-seq pipelines. Together, these steps produce a complete molecular profile of the tRNAome.

Workflow of nano tRNA sequencing, integrating small RNA enrichment, tRNA preparation, nanopore-based direct RNA sequencing, and tRNAome-focused bioinformatics.
| Analysis Feature | Basic tRNAome Analysis | Advanced tRNAome Analysis |
| Basecalling for short RNAs | ✓ Optimised for structured, modification-rich tRNAs | ✓ Includes alternative model testing for enhanced accuracy |
| tRNA mapping & isoacceptor identification | ✓ High-confidence mapping to known tRNA references | ✓ Custom reference building for non-model species |
| tRNA abundance quantification | ✓ Read counts, isoacceptor-level profiling | ✓ Normalisation across conditions; differential abundance analysis |
| Modification signature detection | ✓ Identification of high-confidence modification-induced signal shifts | ✓ Single-nucleotide KL-divergence analysis for multi-modification discovery (Ψ, m¹A, m⁷G, U34 variants, i⁶A, etc.) |
| Isoacceptor/isodecoder separation | ✓ Standard isoacceptor resolution | ✓ Enhanced separation using raw signal patterns |
| Nanopore signal interpretation | — | ✓ Signal-level plots, event-space analysis, and motif-associated patterns |
| Comparative tRNAome analysis | — | ✓ Multi-condition, multi-sample comparison; stress/drug response profiling |
| Codon–anticodon adaptation metrics | — | ✓ Alignment of tRNA abundance with codon usage and translational efficiency |
| Modification network analysis | — | ✓ Identification of modification cross-talk (e.g., Ψ–m¹A interplay, U34 pathway changes) |
| Ribo-tRNA integration (optional) | — | ✓ Support for ribosome-associated tRNA profiling (Ribo-tRNAseq) |
| Data visualisation | ✓ Basic bar charts and mapping summaries | ✓ Heatmaps, signal-distribution plots, modification landscape maps |
Different analytical technologies reveal different aspects of tRNA biology. The table below compares nano tRNA sequencing, Illumina RNA-seq, and LC–MS/MS, helping research teams select the most suitable method for their study design.
At CD Genomics, we provide all three platforms—ONT direct RNA sequencing, Illumina RNA-seq, and LC–MS/MS—allowing clients to combine tools or build integrated workflows for deeper insight.
| Feature | Nano tRNA Sequencing (ONT) | Illumina RNA-seq | LC–MS/MS |
| Reads native tRNA molecules | ✔ Yes | ✘ No | ✘ No |
| Reads through structured tRNAs | ✔ Yes | ✘ Often fails RT | ✔ Digested fragments only |
| Detects modifications | ✔ Single-molecule signal shifts | ✘ Modifications erased by RT | ✔ Chemical identity only |
| Identifies modification positions | ✔ Yes, nucleotide-resolved | ✘ No | ✘ No |
| Quantifies tRNA abundance | ✔ High accuracy | ✔ Medium accuracy | ✔ Partial (indirect) |
| Isoacceptor / isodecoder resolution | ✔ High | ✘ Low | ✘ Not applicable |
| Detects multiple modification types | ✔ Ψ, m¹A, m⁷G, i⁶A, U34, etc. | ✘ No | ✔ Limited (depends on chemistry) |
| Full-length tRNA coverage | ✔ Yes | ✘ No | ✘ No |
| Cross-species compatibility | ✔ Universal | ✔ Universal | ✘ Limited |
| Best use case | tRNAome profiling, modification mapping, translation studies | mRNA and lncRNA expression analysis | Identification of modification types, validation |
| Main limitations | Lower throughput, requires specialised mapping | Cannot capture modifications | No positional information |
Because CD Genomics supports ONT, Illumina, and LC–MS/MS platforms, clients can build integrated research strategies—for example, combining nano tRNA sequencing with RNA-seq for transcriptome context or LC–MS/MS for chemical confirmation.
| Category | Requirement | Notes |
| Sample type | Total RNA | Any species (microbes, plants, animals, human-derived samples) |
| Minimum input | ≥ 3 µg total RNA | Higher input improves tRNA enrichment and mapping accuracy |
| RNA integrity | RIN ≥ 7 (Bioanalyzer or equivalent) | Lower RIN may reduce tRNA read quality |
| Purity criteria | A260/280 = 1.8–2.1 A260/230 ≥ 2.0 |
Avoid phenol or ethanol carryover |
| Preservation method | Fresh, flash-frozen, or RNAlater-stabilized RNA | Avoid freeze–thaw cycles |
| DNase treatment | Recommended | Genomic DNA contamination interferes with adapter ligation |
| Sample volume | ≥ 20 µL | Ensure adequate volume for QC and library prep |
| Shipping conditions | Dry ice (preferred) | Ship in RNase-free tubes with clear labels |
| Multiplexing compatibility | Up to 6–12 samples per run | Barcoding options available for multi-condition studies |
Expertise in tRNA Biology
Skilled in nano tRNA sequencing, short RNA processing, and nanopore signal analysis.
Multi-Platform Integration
Supports ONT, Illumina RNA-seq, and LC–MS/MS for combined multi-layer datasets.
Custom Bioinformatics
Offers basic and advanced analysis for mapping, modification detection, and comparative tRNAome studies.
High Quality & Reproducibility
Rigorous QC ensures accurate data, minimal artefacts, and preservation of native tRNA modifications.
End-to-End Scientific Support
Works with research, biotech, and pharma teams to design and interpret translation-focused studies.
Lucas, M.C., Pryszcz, L.P., Medina, R. et al. Quantitative analysis of tRNA abundance and modifications by nanopore RNA sequencing. Nature Biotechnology42, 72–86 (2024).
tRNAs carry a dense network of chemical modifications that regulate their folding, decoding activity, and stability. Until recently, researchers relied on indirect methods—such as mass spectrometry or cDNA-based RNA-seq—to infer these marks. These approaches either lacked positional information or erased modifications during reverse transcription.
This study tested whether Oxford Nanopore's direct RNA sequencing could deliver a unified view of tRNA abundance, isoacceptor usage, and modification signatures within a single experiment.
This work provides one of the strongest proof-of-concept demonstrations for native tRNA sequencing, offering insights now routinely leveraged in our nano tRNA sequencing service.
Native tRNAs were extracted from Schizosaccharomyces pombe (wild-type and enzyme-knockout strains). The workflow included:
This approach allowed the authors to characterise modification probabilities and assign modification sites to specific enzymes.
The authors demonstrated that nanopore sequencing can distinguish modified from unmodified tRNA positions with high confidence. Using the Ψ model, they visualised clear probability peaks at known pseudouridine sites, while knockout strains displayed corresponding signal loss.

Nanopore-derived probability distribution for Ψ55 in native tRNAs, showing a strong high-probability peak consistent with known pseudouridine modification.
This study confirms that nanopore direct RNA sequencing is a powerful single-molecule approach for analysing both tRNA abundance and modification landscapes. Importantly:
Nano tRNA sequencing allows you to profile the full-length native tRNA pool (the "tRNAome"), including isoacceptor usage and read counts, and to detect chemical modification signatures directly from nanopore current signals, making it uniquely suited for translation- and epitranscriptomic-focused research.
Unlike standard short-read RNA-seq, which typically reverse-transcribes and therefore loses many tRNA modifications and struggles with short, structured RNAs, nano tRNA sequencing reads native tRNAs directly via nanopore and preserves modification signatures; unlike LC–MS/MS, which identifies modification chemistry but lacks positional and isoacceptor context, nano tRNA sequencing provides both quantification and positional insight.
This approach is ideal when you need to quantify tRNA species and isoacceptors, study how tRNA modifications change under stress or treatment, investigate codon–anticodon adaptations, or explore translation regulation mechanisms in nonclinical research programs.
Yes. The method uses nanopore direct RNA reads to map modification-induced current shifts and, through specialised algorithms, can assign modification probabilities to specific nucleotides in tRNA molecules, enabling detection of modifications such as Ψ, m¹A, m⁷G, i⁶A, U34 variants and others.
Yes. Because it uses native RNA and long-read nanopore technology, the workflow supports tRNAome profiling from microbes, plants, animals, and human-derived samples. Custom reference creation and isoacceptor annotation enable use in non-model species.
To design an effective study, define your biological question (e.g., modification dynamics, stress response), consider appropriate biological replicates, ensure high-quality RNA input (e.g., RIN ≥7), and optionally integrate additional platforms (e.g., Illumina RNA-seq for transcriptome context or LC–MS/MS for chemical validation) to build a comprehensive translational profile.
Absolutely. Many programmes benefit from a multi-platform strategy: nano tRNA sequencing for modification-aware tRNAome profiling, Illumina RNA-seq for global gene expression, and LC–MS/MS for fine chemical identity of modifications. This integrative approach boosts mechanistic insight.
We recommend high-quality total RNA with sufficient input, clear labelling, and proper storage/handling to preserve structured and modified tRNAs. Proper sample preparation ensures robust mapping and modification detection.
Yes. The service is designed for research use only and supports publication-quality output, including quantification, modification profiles, and comparative analysis workflows adapted for translational research, CRO projects, biotech studies and academic publications.
1. tRNA Abundance Bar Plot (Isoacceptor Profiling)
2. Modification Probability Heatmap
3. Nanopore Signal Trace (Squiggle Plot) for Modification Detection

References
For research purposes only, not intended for personal diagnosis, clinical testing, or health assessment